{"nct_id":"NCT02614196","title":"Evaluation of Efficay & Safety of Galcanezumab in the Prevention of Episodic Migraine- the EVOLVE-2 Study","status":"COMPLETED","status_verified_date":"2020-06","start_date":"2015-12-04","start_date_type":"ACTUAL","primary_completion_date":"2017-03-29","primary_completion_date_type":"ACTUAL","completion_date":"2018-10-05","completion_date_type":"ACTUAL","phases":["PHASE3"],"tickers":["LLY"]}